Despite its relative rarity in clinical practice, the Ross procedure provides a survival benefit over mechanical aortic valve replacement in young and middle-aged patients, suggests a meta-analysis published in JAMA Cardiology and presented at the European Society of Cardiology (ESC) Congress in Munich.

Investor’s Business Daily published a profile of Johns Hopkins physician Helen Brooke Taussig, MD, who overcame an initial rejection to medical school due to gender discrimination and went on to create the field of pediatric cardiology.

Adult congenital heart disease (ACHD)-related heart failure (HF) hospitalizations have increased in recent years and are associated with disproportionately higher costs, procedural burden and health resource use, according to new research published in the Journal of the American Heart Association.

More than three-fourths of patients who received percutaneous balloon mitral valvuloplasty (PBMV) at a center in Brazil maintained procedural benefit over a median follow-up of 8.3 years, researchers reported in JACC: Cardiovascular Interventions.

CMS’s advisory committee appears to be split on whether procedural volume requirements should be required for centers to begin and maintain transcatheter aortic valve replacement (TAVR) programs.

Harvard University bioengineers have created a 3D model of a human’s left ventricle that they believe could be used to test drugs and study diseases.

Researchers from Weill Cornell Medicine in New York are worried the extension of transcatheter aortic valve replacement (TAVR) to younger, intermediate-risk patients is outpacing clinical evidence.

Mitral valve operations are the fastest-growing type of heart procedure, according to an analysis of the Society of Thoracic Surgeons’ Adult Cardiac Surgery database—but researchers believe interventions at earlier stages could further improve outcomes.